Does POLYMYXIN B Cause Off label use? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Off label use have been filed in association with POLYMYXIN B (polymyxin b sulfate and trimethoprim sulfate). This represents 13.2% of all adverse event reports for POLYMYXIN B.
85
Reports of Off label use with POLYMYXIN B
13.2%
of all POLYMYXIN B reports
11
Deaths
53
Hospitalizations
How Dangerous Is Off label use From POLYMYXIN B?
Of the 85 reports, 11 (12.9%) resulted in death, 53 (62.4%) required hospitalization, and 3 (3.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POLYMYXIN B. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does POLYMYXIN B Cause?
Drug ineffective (260)
Macular degeneration (168)
Pain (66)
Drug hypersensitivity (62)
Nausea (62)
Acute kidney injury (53)
Pyrexia (43)
Malaise (42)
Paraesthesia oral (42)
Infusion related reaction (40)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which POLYMYXIN B Alternatives Have Lower Off label use Risk?
POLYMYXIN B vs POLYMYXIN B\TRIMETHOPRIM
POLYMYXIN B vs POLYVINYL ALCOHOL\POVIDONE
POLYMYXIN B vs POMALIDOMIDE
POLYMYXIN B vs POMALYST
POLYMYXIN B vs PONATINIB